PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 4 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Rheediinoside B showed greater cytotoxic potency and antioxidant properties than Rheediinoside A against T98G, A431, PC3, and B16-F1 cell lines [PMID:19896681]. Entadin lectin showed antiproliferative effects against lung cancer [PMID:32685806].
The species exhibits promising anti-inflammatory and anti-diabetic activity [PMID:36840636].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 19896681 (2010) — Rheediinosides A and B, two antiproliferative and antioxidant triterpene saponins from Entada rheedii. · Phytochemistry
- 2.PMID: 32685806 (2020) — Biochemical Characterization of Lactose Binding Entadin Lectin from Entada rheedii Seeds with Cytotoxic Activity against Cancer Cell Lines. · ACS omega
- 3.PMID: 36840636 (2024) — Nutritional characterization of an underutilized legume Entada rheedii Spreng. seeds and validation of its folklore uses. · Natural product research
- 4.PMID: 22876743 (2012) — Coltsfoot as a potential cause of deep vein thrombosis and pulmonary embolism in a patient also consuming kava and blue vervain. · Journal of dietary supplements